Preclinical evaluation of 131I-Bevacizumab — A prospective agent for radioimmunotherapy in VEGF expressing cancers

No Thumbnail Available

Click here to download

0119.htm (3.79 KB)

Date

2017

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Preclinical evaluation, 131I-Bevacizumab, radioimmunotherapy, VEGF expressing cancer

Source

Applied Radiation and Isotopes, 2017. Vol. 123: pp. 109-113

URI

http://hdl.handle.net/123456789/14843

Collections

2017